CLAS-I
Cholesterol Lowering Atherosclerosis Study - I

Purpose
To determine whether combined therapy with colestipol hydrochloride plus niacin will produce clinically significant changes in coronary, carotid and femoral artery atherosclerosis, and coronary bypass grafts

References
Blankenhorn DH, Nessim SA, Johnson RL, et al: Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987, 257:3233–3240.
Blankenhorn DH, Azen SP, Crawford DW, et al: Effects of colestipol-niacin therapy on human femoral atherosclerosis. Circulation 1991, 83:438–447.

Voltar

Apoio: Libbs Farmacêutica Farmacêutica